The Blog

Regulatory Science Playbook

Accelerating medical tech to advance public health

An ever-expanding landscape of new medical products and therapies demands an equally fast-moving evolution of regulatory actions and policy. From brand new drugs to insulin delivery devices and cancer screening equipment, agencies including the Food & Drug Administration and the Center for Drug Evaluation & Research face the challenges of rapidly evolving science and technology. (more…)

Read More

Improvement Gets a Partner

With CP2I, organizations embrace efficiency and innovation

Doing more with less is the new normal for federal government organizations. Government leaders are expected to manage change, stay current, and deliver more and better services or products—and to do so with stagnant or shrinking budgets and resources. (more…)

Read More
arrow_upward